AR224095A1 - Procedimiento de preparacion de nuevos derivados de ditiol-1,2 tiona-3 - Google Patents
Procedimiento de preparacion de nuevos derivados de ditiol-1,2 tiona-3Info
- Publication number
- AR224095A1 AR224095A1 AR266495A AR26649577A AR224095A1 AR 224095 A1 AR224095 A1 AR 224095A1 AR 266495 A AR266495 A AR 266495A AR 26649577 A AR26649577 A AR 26649577A AR 224095 A1 AR224095 A1 AR 224095A1
- Authority
- AR
- Argentina
- Prior art keywords
- ditiol
- tiona
- procedure
- preparation
- new derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/08—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/38—One sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7603604A FR2340730A1 (fr) | 1976-02-10 | 1976-02-10 | Nouveaux derives du dithiole-1,2, leur preparation et les compositions qui les contiennent |
FR7638901A FR2374906A2 (fr) | 1976-12-23 | 1976-12-23 | Nouveaux derives du dithiole-1,2, leur preparation et les compositions qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
AR224095A1 true AR224095A1 (es) | 1981-10-30 |
Family
ID=26219294
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AR266495A AR224095A1 (es) | 1976-02-10 | 1977-02-09 | Procedimiento de preparacion de nuevos derivados de ditiol-1,2 tiona-3 |
Country Status (26)
Country | Link |
---|---|
US (1) | US4110450A (es) |
JP (1) | JPS5822119B2 (es) |
AR (1) | AR224095A1 (es) |
AT (1) | AT348535B (es) |
AU (1) | AU509092B2 (es) |
CA (1) | CA1073906A (es) |
CH (2) | CH618699A5 (es) |
DE (1) | DE2705641C3 (es) |
DK (1) | DK55477A (es) |
EG (1) | EG13739A (es) |
ES (3) | ES455790A1 (es) |
GB (1) | GB1518071A (es) |
HK (1) | HK17481A (es) |
HU (1) | HU172528B (es) |
IE (1) | IE44561B1 (es) |
IL (1) | IL51403A (es) |
KE (1) | KE3126A (es) |
LU (1) | LU76728A1 (es) |
MY (1) | MY8200001A (es) |
NL (1) | NL171985C (es) |
OA (1) | OA05565A (es) |
PH (1) | PH12367A (es) |
PT (1) | PT66175B (es) |
SE (1) | SE427274B (es) |
SU (1) | SU683622A3 (es) |
ZM (1) | ZM1477A1 (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5001125A (en) | 1984-03-26 | 1991-03-19 | Janssen Pharmaceutica N.V. | Anti-virally active pyridazinamines |
RU2205179C2 (ru) * | 1997-10-27 | 2003-05-27 | НьюроСёрч А/С | Производное гомопиперазина и фармацевтическая композиция |
WO2001085142A1 (en) | 2000-05-05 | 2001-11-15 | Wisconsin Alumni Research Foundation | Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy |
KR100491318B1 (ko) * | 2002-11-26 | 2005-05-24 | 씨제이 주식회사 | 올티프라즈(Oltipraz) 제조방법 |
AU2005329423A1 (en) | 2004-09-20 | 2006-09-28 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors |
WO2006034315A2 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes |
AR051202A1 (es) | 2004-09-20 | 2006-12-27 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa |
MX2007003321A (es) | 2004-09-20 | 2007-06-05 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso como agentes terapeuticos. |
CA2580845A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase |
CN101083994A (zh) | 2004-09-20 | 2007-12-05 | 泽农医药公司 | 杂环衍生物及其用作硬脂酰CoA去饱和酶抑制剂的用途 |
US7951805B2 (en) | 2004-09-20 | 2011-05-31 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase |
BRPI0611187A2 (pt) | 2005-06-03 | 2010-08-24 | Xenon Pharmaceuticals Inc | derivados aminotiazàis como inibidores da estearoil-coa desaturase humana |
CA2698463A1 (en) * | 2007-08-31 | 2009-08-06 | Cylene Pharmaceuticals, Inc. | Therapeutic kinase modulators |
US20160376259A1 (en) * | 2015-06-25 | 2016-12-29 | St Ip Holding Ag | Methods for Preparing Oltipraz |
WO2016207914A2 (en) * | 2015-06-25 | 2016-12-29 | St Ip Holding Ag | Methods for preparing oltipraz |
WO2018047002A1 (en) | 2016-09-12 | 2018-03-15 | St Ip Holding Ag | Formulations of 4-methyl-5-(pyrazin-2-yl)-3h-1.2-dithiole-3-thione, taste-modified formulations, and methods of making and using same |
WO2018047013A1 (en) | 2016-09-12 | 2018-03-15 | St Ip Holding Ag | Formulations of 4-methyl-5-(pyrazin-2-yl)-3h-1, 2-dithiole-3-thione, and methods of making and using same |
EP3762104A2 (en) | 2018-03-07 | 2021-01-13 | ST IP Holding AG | Combination compositions and therapies comprising 4-methyl-5-(pyrazin-2-yl)-3h-1,2-dithiole-3-thione, and methods of making and using same |
US11135220B1 (en) | 2020-04-08 | 2021-10-05 | St Ip Holding Ag | Methods of treating viral infections with formulated compositions comprising 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1526768A (fr) | 1963-01-16 | 1968-05-31 | Procédé de préparation de dérivés sulfoniques de dithiole-1, 2 thiones-3 diversement substituées, et applications des produits ainsi obtenus |
-
1977
- 1977-02-02 NL NLAANVRAGE7701107,A patent/NL171985C/xx not_active IP Right Cessation
- 1977-02-08 HU HU77RO00000914A patent/HU172528B/hu unknown
- 1977-02-08 IL IL7751403A patent/IL51403A/xx unknown
- 1977-02-09 AR AR266495A patent/AR224095A1/es active
- 1977-02-09 DK DK55477A patent/DK55477A/da not_active Application Discontinuation
- 1977-02-09 CH CH158277A patent/CH618699A5/fr not_active IP Right Cessation
- 1977-02-09 US US05/766,966 patent/US4110450A/en not_active Expired - Lifetime
- 1977-02-09 GB GB5365/77A patent/GB1518071A/en not_active Expired
- 1977-02-09 EG EG78/77A patent/EG13739A/xx active
- 1977-02-09 SE SE7701460A patent/SE427274B/xx not_active Application Discontinuation
- 1977-02-09 JP JP52013472A patent/JPS5822119B2/ja not_active Expired
- 1977-02-09 PT PT66175A patent/PT66175B/pt unknown
- 1977-02-09 CA CA271,425A patent/CA1073906A/fr not_active Expired
- 1977-02-09 AU AU22138/77A patent/AU509092B2/en not_active Expired
- 1977-02-09 ZM ZM14/77A patent/ZM1477A1/xx unknown
- 1977-02-09 PH PH7719438A patent/PH12367A/en unknown
- 1977-02-09 SU SU772449656A patent/SU683622A3/ru active
- 1977-02-09 LU LU76728A patent/LU76728A1/xx unknown
- 1977-02-09 IE IE270/77A patent/IE44561B1/en unknown
- 1977-02-10 DE DE2705641A patent/DE2705641C3/de not_active Expired
- 1977-02-10 AT AT90277A patent/AT348535B/de not_active IP Right Cessation
- 1977-02-10 ES ES455790A patent/ES455790A1/es not_active Expired
- 1977-02-10 OA OA56067A patent/OA05565A/xx unknown
- 1977-05-11 ES ES458689A patent/ES458689A1/es not_active Expired
- 1977-05-11 ES ES458688A patent/ES458688A1/es not_active Expired
-
1979
- 1979-11-19 CH CH1030879A patent/CH619463A5/fr not_active IP Right Cessation
-
1981
- 1981-04-30 HK HK174/81A patent/HK17481A/xx unknown
- 1981-05-06 KE KE3126A patent/KE3126A/xx unknown
-
1982
- 1982-12-30 MY MY1/82A patent/MY8200001A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR220004A1 (es) | Procedimiento para la preparacion de derivados de 4,4-dimetil-2-imidazolidinona | |
AR224095A1 (es) | Procedimiento de preparacion de nuevos derivados de ditiol-1,2 tiona-3 | |
RO71931A (ro) | Procedeu pentru prepararea unor feniletilamino-derivati ai 3,4-dihidro-2h-izochinolin-1-onei sau ai 1,2,3,4-tetrahidro-5h-benzazepin-1-onei | |
RO75777A (ro) | Procedeu pentru prepararea unor 1,2-benzizotiazolin-3-one | |
SE7808059L (sv) | Forfarande for framstellning av 1,2,4-triazin-5-on-derivat | |
NO151365C (no) | Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater. | |
MX4664E (es) | Procedimiento mejorado para la preparacion de derivados de n-fosfonometilglicina | |
SE7604475L (sv) | Forfarande for framstellning av 1,1,1-triaryl-alkylaminer | |
MX5256E (es) | Procedimiento para la preparacion de derivados de 20,21-dinoreburnamenina | |
RO77485A (ro) | Procedeu pentru prepararea 1,2,3-tiadiazol-3-in-5-ilidenureelor | |
MX4161E (es) | Procedimiento de preparacion de compuestos de amino-alcoxi-4(2h)-piranona-2,3 substituidos condensados-5,62 | |
SE436026B (sv) | Forfarande for framstellning av 13,14-dehydroprostaglandiner | |
AR218498A1 (es) | Procedimiento de preparacion de derivados de 1,3-difenoxipropan-2-ona | |
AR211570A1 (es) | Procedimiento de preparacion de nuevos derivados de 8-oxi-5-(2-hidroxi-3-aminopropoxi)-carbostirilo | |
SE439631B (sv) | Forfarande for framstellning av 3,4-dihydrokarbostyrilderivat | |
RO75589A (ro) | Procedeu pentru prepararea 2,6-metan-2h-1-benzoxocinei | |
SE7804878L (sv) | Forfarande for framstellning av 1,2-dikloretan | |
ES493931A0 (es) | Procedimiento de preparacion de nuevos derivados de la 3,4,5-trimetoxi-cinamoil-piperazina | |
SE7707125L (sv) | Forfarande for framstellning av 7-(alfa-(2,3, - dihydro-2-oxo-1h- bensimidazol -1- ylkarbomyl-amino) arylacetamido ) cefalasporiner | |
SE428922B (sv) | Forfarande for framstellning av 13, 14-dihydro-11-dioxi-prostaglandiner | |
ES494286A0 (es) | Procedimiento de preparacion de nuevos derivados 1,1,2-tri- fenilpropanos y -propenos | |
AR230835A1 (es) | Procedimiento para la obtencion de derivados de 2,1,3-tiadiazin-4-ona-2,2-dioxido | |
NO774503L (no) | Fremgangsmaate for fremstilling av oktahydro-indolo(2,3,a)-chinoliziner | |
NO772809L (no) | Fremgangsm}te for fremstilling av 2,6-diterti{rt-butylfenol | |
SE7608453L (sv) | Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner |